Sign in
4

Changes in Ownership

ENDRA Life Sciences Inc. Filed Acc 0001209191-22-030307

Chief Executive Officer bought 5,100 shares at $0.19 ($969)

From the SEC's structured data for this filing

Trades in this filing

Michelon Francois Roger · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-05-17 Purchase : show line 1 in the form +5,100 $0.19 $969 97,191 D
Open-market purchases · 5,100 sh · avg $0.19 · $969
Loading xslF345X03/doc4.xml…